Showing results (561-570 of 703) with videos related to

Sort By:
Pageof 71
The Journal of Clinical Endocrinology and Metabolism|August 28, 2014
Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International WorkshopShonni J Silverberg, Bart L Clarke, Munro Peacock, et al.
Frontiers in Endocrinology|April 4, 2013
Risk of fracture with thiazolidinediones: an individual patient data meta-analysisMarloes T Bazelier, Frank de Vries, Peter Vestergaard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 25, 2014
HIV infection and its association with an excess risk of clinical fractures: a nationwide case-control studyDaniel Prieto-Alhambra, Robert Güerri-Fernández, Frank De Vries, et al.
British Journal of Cancer|April 5, 2025
YKL-40 and risk of incident cancer in early type 2 diabetes: a Danish cohort studyAlisa D Kjaergaard, Allan A Vaag, Verena H Jensen, et al.
Archives of Internal Medicine|July 25, 2012
Timing of acute myocardial infarction in patients undergoing total hip or knee replacement: a nationwide cohort studyArief Lalmohamed, Peter Vestergaard, Corinne Klop, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 21, 2026
Profiling bone status indices reveals evidence of a low-turnover bone phenotype in type 2 diabetes: findings from the DiaFALL cohortNicklas H Rasmussen, Annika Vestergaard Kvist, Asger Ahlmann Bech, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 11, 2011
The risk of fracture in patients with multiple sclerosis: the UK general practice research databaseMarloes T Bazelier, Tjeerd van Staa, Bernard M J Uitdehaag, et al.
Multiple Sclerosis and Related Disorders|January 9, 2023
Real-world experience of cladribine treatment in relapsing-remitting multiple sclerosis: A Danish nationwide studyPer Soelberg Sorensen, Luigi Pontieri, Hanna Joensen, et al.
Pituitary|August 20, 2025
Semaglutide treatment in hypothalamic obesity: Two-Year outcomes on body composition, appetite, and quality of lifeErlend Gjersdal, Frederik Østergaard Klit, Kåre Schmidt Ettrup, et al.
Pageof 71